US authority increases subsidies for single-use duodenoscopes – which benefits both Ambu and Boston Scientific

Accessing single-use duodenoscopes in the US will be a lot easier now that the US authority Center for Medicare & Medicaid Services (CMS) has granted additional reimbursement for this product type, which Boston Scientific first introduced in the US market. Since then, Danish Ambu has launched its own version in the US, and the two companies are now competing for customers.

Photo: Marcio Jose Sanchez/AP/Ritzau Scanpix

US hospitals might be getting more of an incentive to choose single-use duodenoscopes over traditional reusable scopes.

This is after the Center for Medicare & Medicaid Services (CMS), which runs US health platforms Medicare and Medicaid, has granted an additional reimbursement for single-use duodenoscopes to be used for examinations of the gall bladder and the pancreas, for example.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs